Selenium-Enriched Yeast in Thyroid Hormone & Metabolic Health: Technology Licensing & Clinical Data
Selenium-Enriched Yeast in Thyroid Hormone & Metabolic Health: Technology Licensing & Clinical Data
The thyroid gland contains the highest concentration of selenium per gram of tissue in the human body. Selenium is an indispensable catalytic constituent of Iodothyronine Deiodinase enzymes ($D1, D2, D3$), which convert inactive thyroxine ($T_4$) into bio-active triiodothyronine ($T_3$).
$$\text{Inactive Thyroxine } (T_4) \xrightarrow{\text{Iodothyronine Deiodinase (Se-Dependent)}} \text{Active Triiodothyronine } (T_3) + I^-$$
In patients suffering from autoimmune thyroiditis (Hashimoto's thyroiditis) or metabolic sluggishness, supplementing with 3,320 PPM Selenium-Enriched Yeast (Saccharomyces cerevisiae)—containing $\ge 95%$ organic Selenomethionine ($SeMet$)—reduces anti-thyroid peroxidase (anti-TPO) antibody titers and optimizes metabolic rate.
This guide outlines the endocrinology science, bioprocess SOPs, and technology transfer package for Probiota Innovations' 3,320 PPM Selenium Yeast Platform.
1. Clinical Rationale: Deiodinase Activation & Anti-TPO Reduction
THYROID METABOLISM PATHWAY:
1. Dietary Selenomethionine (SeMet) -> Absorbed via intestinal methionine channels
2. Thyroid Tissue Incorporation -> Activates Deiodinases (T4 -> T3 conversion)
3. Antioxidant Protection -> GPx3 neutralizes excess H2O2 during iodine organification
4. Immune Modulation -> Reduces circulating anti-TPO & anti-TG antibody levels
2. Technical Asset Specifications for Clinical Brands
| Quality Attribute | Clinical Endocrinology Specification |
|---|---|
| Total Selenium Potency | 3,320 PPM (3.32 mg Se / gram yeast) |
| Organic Speciation | $\ge 95.0%$ Selenomethionine ($SeMet$) via HPLC-ICP-MS |
| Inorganic Selenite Limit | $< 1.0%$ (Ultra-safe clearance; zero pro-oxidant risk) |
| Heavy Metals (USP <2232>) | Lead $\le 2.0$ ppm, Mercury $\le 0.1$ ppm, Arsenic $\le 1.0$ ppm |
| Dosage Accuracy | $100 \ \mu\text{g} \text{ to } 200 \ \mu\text{g}$ Se delivered per $30-60\text{mg}$ yeast powder |
3. Technology Transfer & Bioprocess Handover Package
Pharma CDMOs and endocrinology supplement brands acquiring the technology transfer package receive:
- Cryopreserved Master Seed Vials: S. cerevisiae strain tailored for high-density biomass accumulation and organic selenite incorporation.
- Fed-Batch Inoculation SOPs: Automated selenite feeding profiles preventing cell lysis during high-yield fermentation runs.
- Washing & Purification SOPs: Multi-stage centrifugal cell washing removing unreacted inorganic selenite prior to thermal inactivation and spray-drying.
- Full IP Sale or Regional Out-Licensing: Flexible licensing deal models.
Partner with Probiota Innovations for Endocrinology Biotech
Acquire 3,320 PPM Selenium Yeast technology backed by complete clinical dossiers.
- View Dedicated 3,320 PPM Selenium Yeast Asset Page
- Explore Technology Transfer Portal
- Submit a Licensing Inquiry & Request Technical Dossiers
Related Technology Transfer Resources:
- 3,320 PPM Selenium-Enriched Yeast Technology Transfer
- Selenium-Enriched Yeast in Liver Detoxification Therapeutics
- Biotechnology Technology Transfer Guide: Fermentation IP Acquisition
Recommended Manufacturing Solution
Want to discuss your formulation?
Our experts help brands launch technically complex probiotic and functional gummies.
